Keyphrases
COVID-19
100%
Patient Demographics
50%
Long-term Consequences
50%
Antibiotics
50%
Oxygenation
50%
Non-invasive Method
50%
Critical Illness
50%
ICU Patients
50%
Therapeutic Anticoagulation
50%
Invasive Procedures
50%
Immunomodulation
50%
Lung Protection
50%
Anti-IL-6
50%
Acute Respiratory Failure
50%
No-place
50%
Evidence-based Management
50%
Patients with COVID-19
50%
COVID-19 Related
50%
Organ Support
50%
Invasive Ventilation
50%
Biochemistry, Genetics and Molecular Biology
Interleukin 6
100%
Oxygenation
100%
Anticoagulation
100%
Immunomodulation
100%
SARS Coronavirus
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
100%
Infection
50%
Antivirus Agent
50%
Interleukin 6
50%
Critical Illness
50%
Acute Respiratory Failure
50%
Immunomodulation
50%
SARS Coronavirus
50%
Neuroscience
Interleukin 6
100%
SARS Coronavirus
100%